| Time |
Event |
Location |
| 6:00-7:30pm |
Opening Session |
Grand Ballroom |
| 6:00-6:05pm |
Welcome remarks and introduction
Lawrence Corey
University of Washington and Fred Hutchinson Cancer Research Center |
| 6:05-6:10pm |
Message from Christine Gregoire
Governor of Washington |
| 6:10-6:20pm |
Welcome to Seattle
Patricia McInturff
Director, Seattle Department of Human Services |
| 6:20-6:50pm |
Responding to the AIDS Pandemic
Tachi Yamada
Director, Global Health Program
Bill and Melinda Gates Foundation |
| 6:50-7:10pm |
AIDS Vaccine 2007: Much Accomplished, Much to do
Anthony S. Fauci
Director, National Institutes of Allergy and Infectious Diseases |
| 7:10pm-7:30 |
Finding a Path to Development of an HIV Vaccine
Barton Haynes
Duke University Medical Center |
| 7:30-9:30pm |
Poster Session #1 and Welcome Reception |
Metropolitan Ballroom |
| 8:00-9:00pm |
Poster Discussion #1:
Social, Ethical, and Regulatory Issues in Clinical Trials Implementation
Gabrielle Lamourelle
Butch McKay
Kimberly Louis
Kevin Fisher
Chawetson Namwat
Zuhayr Kafaar
|
Metropolitan Ballroom |
| Time |
Event |
Location |
| 7:00-8:30am |
Breakfast Buffet and Coffee Service |
Grand Ballroom Foyer and Willow Ballroom |
| 8:30-10:00am |
Plenary #1
Julie McElrath, Chair
David Baker - Computational design of novel immunogens
Robin Weiss - The nature of protective antibodies
Mark Feinberg - From test of concept to global access: needs and questions moving forward
|
Grand Ballroom |
| 10:00-10:30am |
Break - Food and Beverages Available |
| 10:30am-12:30pm |
Oral Abstract Session #1
Vaccine Concepts and Design Part 1
Chairs: Carolyn Williamson and Saladin Osmanov
Pengfei Jiang
Heather Desaire
Patrice Debre
Y. Liu
Lance Ching
Robert Luallen
Susan Zolla-Pazner
Xunqing Jiang
|
Grand Ballroom B |
| 10:30am-12:30pm |
Oral Abstract Session #2
Clinical trials Part 1
Chairs: Nelson Michael and Yves Levy
Sandhya Vasan
Michael Keefer
Eric Sandstrom
Paul Goepfert
Deborah Persaud
Johannes Hain
Eftyhia Vardas
|
Grand Ballroom C |
| 10:30am-12:30pm |
Oral Abstract Session #3
T Cell and Mucosal Immunity
Chairs: Rafick Sekaly and Helen Horton
Meritxell Genesca Ferrer
David Kaufman
Kimberly Schoenly
Dennis Hartigan-O'Connor
Uma Malhorta
Sheri Dubey
Bonnie Colleton
Sylvie Le Gall
|
Grand Ballroom D |
| 12:30-1:30pm |
Lunch Buffet |
2nd and 3rd floor Foyers |
| 1:30-3:00pm |
Symposium #1
New Vectors and Adjuvants
John Shiver, Chair
Tom Dubensky - Harnessing (and controlling) L. monocytogenes to treat and prevent human disease
Hussein Y Naim - Live attenuated measles virus vector
Dan Barouch - Novel adenovirus vector-based vaccines for HIV-1
Anna-Lise Williamson - BCG as an HIV vaccine vector
|
Grand Ballroom AB |
| 1:30-3:00pm |
Symposium #2
Mucosal Immunity
Bonnie Matheson, Chair
David Koelle - Tissue-homing properties of human HSV-2-specific CD4 and CD8 T-cells
Barbara L. Shacklett - Functional heterogeneity of HIV-specific T-cells in mucosal tissues
Jo-Ann Shelley Passmore - Mucosal assessment of T cell magnitude and specificity during HIV infection: feasibility?
Robin Shattock - Mucosal protection to HIV-1: what to induce and how to measure it
|
Grand Ballroom C |
| 3:00-3:30pm |
Break - Food and Beverages Available |
| 3:30-5:00pm |
Round Table #1
Innate Immunity and Adjuvants: Is it all TLR?
Ken Rosenthal, Moderator
David Nemazee
Robert Seder
Michael Gale
Heather Davis
|
Grand Ballroom AB |
| 3:30-5:00pm |
Round Table #2
New Primate Models: Will they help HIV Vaccine Development?
Nancy Haigwood, Moderator
Martha Marthas
Jim Hoxie
Norman Letvin
Sal Butera
|
Grand Ballroom C |
| 5:30-10:30pm |
Dinner Excursion |
Tillicum Village |
| Time |
Event |
Location |
| 7:00-8:30am |
Breakfast Buffet and Coffee Service |
Grand Ballroom Foyer and Willow Ballroom |
| 8:30-10:00am |
Plenary #2
Pontiano Kaleebu, Chair
Amalio Telenti - Human genome analysis - clues to vaccine development
Otto Yang - CTL and the control of HIV-1 replication
Glenda Gray - Future directions for HIV vaccine research in high HIV prevalence developing country settings
|
Grand Ballroom |
| 10:00-10:30am |
Break - Food and Beverages Available |
| 10:30am-12:30pm |
Oral Abstract Session #4
Vaccine Concepts and Design Part 2
Chairs: Wayne Koff and Steve Patterson
Denis Gaucher
Danilo Casimiro
Frederic Martinon
Lauren Hirao
Jinyan Liu
Petra Mooij
David Clarke
Shiu-Lok Hu
|
Grand Ballroom B |
| 10:30am-12:30pm |
Oral Abstract Session #5
B Cell Immunity
Chairs: Lynn Morris and Dennis Burton
S. Munir Alam
Erin Scherer
Christianne Moog
Abraham Pinter
Weimin Liu
Catherine Blish
Nancy Haigwood
Bruce Brown
|
Grand Ballroom C |
| 10:30am-12:30pm |
Oral Abstract Session #6
Animal Models
Chairs: Louis Picker and Marta Marthas
James Binley
Kenneth Chan
Jodi Craigo
David Evans
Cristian Apetrei
Rama Rao Amara
Guido Silvestri
Jean Boyer
|
Grand Ballroom D |
| 12:30-1:30pm |
Lunch Buffet |
2nd and 3rd floor Foyers |
| 1:30-3:30pm |
Symposium #3
Clinical Trials
Susan Buchbinder, chair
Michael Robertson - Update on the Merck Ad5 phase II trial (the STEP study--Merck V520 protocol 023/HVTN 502)
Supachai Perks-Ngarm - Challenges in conducting large community-based trials in Asia
Helen Horton - Mapping HIV-1 T cell epitopes in humans participating in clinical trials of candidate HIV-1 vaccines
Steve DeRosa - Comparison of vaccine responses using pox vs ad vectors: the HVTN experience
Scott Hammer - HIV vaccine efficacy trials in a changing environment: potential effects of male circumcision, PrEP, and microbicides
Richard Koup - Update on safety and immunogenicity of VRC products
|
Grand Ballroom AB |
| 1:30-3:30pm |
Round Table #3
Defining the Specificities in Broadly Neutralizing Sera
Leo Stamatatos, moderator
John Mascola
Dennis Burton
George Shaw
James Binley
Alexandra Trkola
Lynn Morris
Susan Zola Panzer
|
Grand Ballroom C |
| 3:30-4:00pm |
Break - Food and Beverages Available |
| 4:00-6:00pm |
Symposium #4
Host Immunity and the Control of Viral Infection
Giuseppe Pantaleo, Chair
Marcus Altfeld - Innate immunity in HIV-1 infection
Louis Picker - Central vs. effectors memory T cells
Rafick-Pierre Sekaly - Survival mechanisms of memory T cells: implications for vaccine development
Raymond Welsh - Pathogenic epitomes, heterogonous immunity, and vaccine design |
Grand Ballroom AB |
| 4:00-6:00pm |
Symposium #5
Therapeutic Vaccines
Brigitte Autran, Chair
Nina Bhardwaj - Targeting dendritic cells for immunotherapeutic purposes
Pierre Alexandre Bart - Is there a future for therapeutic vaccines?
George Pavlakis - Benefit of DNA therapeutic vaccination in macaques
Mary Marovich - Dendritic cell vaccination with HIV antigens in humans
|
Grand Ballroom C |
| 6:00-8:00pm |
Poster Session #2
Wine and Cheese Reception |
Metropolitan Ballroom |
| 6:30-7:00pm |
Poster Discussion #2
Clinical Trial Site Development
Lu Yin
Eftyhia Vardas
Suchada Chinaworapong
|
Metropolitan Ballroom |
| Time |
Event |
Location |
| 7:00-8:30am |
Breakfast Buffet and Coffee Service |
Grand Ballroom Foyer and Willow Ballroom |
| 8:30-10:00am |
Symposium #6
Neutralization and B-Cell Response
David Ho, Chair
Barton Haynes - Antibody polyspecificity and neutralization of HIV
Christiane Moog - Inhibitory activity of antibodies evaluated on different type of primary target cells
Bing Chen - A broadly neutralizing antibody recognizes a fusion-intermediate state of HIV-1 gp41
Dennis Burton
|
Grand Ballroom AB |
| 8:30-10:00am |
Symposium #7
Improving Immunogen Design
Steve Self, Chair
Francine McCutchan - Defining the global epidemiology of HIV
Fusheng Li - Heterologous insert prime-boost vaccination has the potential to overcome HIV-1 antigen diversity
Ralph Wagner - Impact of RNA- and codon-optimization on safety, immunogenicity and efficacy of HIV candidate vaccines
Bette Korber - Characteristics of HIV at acute infection
|
Grand Ballroom C |
| 10:00-10:30am |
Break - Food and Beverages Available |
| 10:30am-12:30pm |
Oral Abstract Session #7
Acute HIV/HIV Transmission
Chairs: George Shaw and Julie Overbaugh
Thomas Hope
Brandon Keele
Terri Wrin
Tanawan Samleerat
Penny Moore
Bhavna Chohan
Eric Hunter
Tuofu Zhu
|
Grand Ballroom B |
| 10:30am-12:30pm |
Oral Abstract Session #8
Clinical Trials Part 2
Chairs: Steve Kent and John Hural
Cecilia Morgan
Scott Hammer
Walter Jaoko
Michael Keefer
Clayton Harro
Ray Dolin |
Grand Ballroom C |
| 10:30am-12:30pm |
Oral Abstract Session #9
Immune Escape
Chairs: Steve DeRosa and Mario Roederer
Todd Allen
Zabrina Brumme
Viv Peut
Julia Richardt
Paul Goepfert
Arne Scheidewind
Ralph Pantophlet
Julian Blanco
|
Grand Ballroom D |
| 12:30-1:30pm |
Lunch Buffet |
2nd and 3rd floor Foyers |
| 1:30-2:45pm |
Plenary #3
Peggy Johnston and Jose Esparza, Co-Chairs
Jose Esparza - The enterprise, progress and challenges
David Montefiori - Emerging issues in humoral response to HIV
Robin Shattock - Emerging issues in mucosal and innate immunity to HIV
Nina Russell - Innovative clinical trial designs to expedite vaccine efficacy evaluation
Bill Snow - The as-yet unrealized potential of the enterprise
|
Grand Ballroom |
| 2:45-3:45pm |
Rapporteurs |
Grand Ballroom |
| 3:45-4:15pm |
Break - Food and Beverages Available |
| 4:15-5:45pm |
Late Breaker Oral Abstracts
Dimiter Dimitrov
Sampa Santra
Robert Palermo
Nicholas Steers
Andrei Kozlov
Mina John
Marta Marthas
|
Grand Ballroom |
| 5:45-6:00pm |
Handover |
Grand Ballroom |